|
David W. Dockhorn, Ph.D., was named Executive Vice President, Clinical Operations in 2003 after previously serving as Senior Vice President, North American Clinical Operations.
Dr. Dockhorn joined PRA International in 1997 as the Vice President of Operations and Regional Director of the Lenexa, Kan. operations. Under Dr. Dockhorn’s leadership, the Lenexa office became PRA’s fastest growing and most profitable trials management center.
In addition to directing the company’s global clinical operations, he is also charged with delivering overall client satisfaction.
Previously, along side his father Dr. Robert Dockhorn, David worked for International Medical Technical Consultants, Inc., or IMTCI, a CRO that was acquired by PRA in 1997. There, he focused on data management and clinical trials, including Phases IIV. He held positions of increasing responsibility, from study coordinator to vice president of clinical research. He also developed a therapeutic expertise in the respiratory field.
Dr. Dockhorn received his Ph.D. in neuroscience From Texas Tech University. | 